全文获取类型
收费全文 | 8516篇 |
免费 | 528篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 117篇 |
妇产科学 | 82篇 |
基础医学 | 1475篇 |
口腔科学 | 94篇 |
临床医学 | 995篇 |
内科学 | 2116篇 |
皮肤病学 | 181篇 |
神经病学 | 699篇 |
特种医学 | 275篇 |
外国民族医学 | 4篇 |
外科学 | 1152篇 |
综合类 | 20篇 |
预防医学 | 447篇 |
眼科学 | 93篇 |
药学 | 678篇 |
中国医学 | 14篇 |
肿瘤学 | 591篇 |
出版年
2023年 | 49篇 |
2022年 | 124篇 |
2021年 | 260篇 |
2020年 | 143篇 |
2019年 | 253篇 |
2018年 | 272篇 |
2017年 | 158篇 |
2016年 | 200篇 |
2015年 | 263篇 |
2014年 | 355篇 |
2013年 | 539篇 |
2012年 | 764篇 |
2011年 | 769篇 |
2010年 | 498篇 |
2009年 | 348篇 |
2008年 | 514篇 |
2007年 | 542篇 |
2006年 | 495篇 |
2005年 | 472篇 |
2004年 | 433篇 |
2003年 | 407篇 |
2002年 | 339篇 |
2001年 | 69篇 |
2000年 | 48篇 |
1999年 | 56篇 |
1998年 | 68篇 |
1997年 | 58篇 |
1996年 | 39篇 |
1995年 | 36篇 |
1994年 | 20篇 |
1993年 | 29篇 |
1992年 | 16篇 |
1991年 | 24篇 |
1990年 | 17篇 |
1989年 | 21篇 |
1988年 | 23篇 |
1987年 | 18篇 |
1986年 | 21篇 |
1985年 | 12篇 |
1984年 | 25篇 |
1983年 | 16篇 |
1982年 | 21篇 |
1981年 | 19篇 |
1980年 | 16篇 |
1979年 | 11篇 |
1978年 | 12篇 |
1977年 | 19篇 |
1976年 | 20篇 |
1967年 | 12篇 |
1903年 | 13篇 |
排序方式: 共有9091条查询结果,搜索用时 0 毫秒
1.
2.
3.
Céline Chipoy Martine Berreur Séverine Couillaud Gilbert Pradal Fran?ois Vallette Caroline Colombeix Fran?oise Rédini Dominique Heymann Frédéric Blanchard 《Journal of bone and mineral research》2004,19(11):1850-1861
The effects of OSM on proliferation and differentiation of osteosarcoma and nontransformed osteoblasts were analyzed. OSM downregulates osteoblast markers but induces the glial fibrillary acidic protein by the combined activation of PKCdelta and STAT3, offering new lines of therapeutic investigations. INTRODUCTION: Oncostatin M (OSM) is a multifunctional cytokine of the interleukin-6 family implicated in embryonic development, differentiation, inflammation, and regeneration of various tissues, mainly the liver, bone, and the central nervous and hematopoietic systems. One particularity of OSM relies on its growth inhibitory and pro-differentiating effects on a variety of tumor cell lines such as melanoma, providing arguments for a therapeutic application of OSM. The objective of this study was to analyze the effects of OSM on osteosarcoma cell lines proliferation and differentiation. MATERIALS AND METHODS: Proliferation was analyzed by 3H thymidine incorporation. Differentiation was analyzed by semiquantitative RT-PCR and immunocytochemistry for various markers. Alizarin red S staining was used to evaluate bone nodule formation. Morphological changes were studied by confocal and electron microscopy. Western blotting, kinases inhibitors, and dominant negative STAT3 were used to identified the signaling pathways implicated. RESULTS: OSM inhibits the growth of rat osteosarcoma cell lines as well as normal osteoblasts, in correlation with induction of the cyclin-dependent kinases inhibitor p21WAF1. However, OSM reduces osteoblast markers such as alkaline phosphatase, osteocalcin, and bone sialoprotein, leading to strong inhibition of mineralized nodule formation. This inhibitory effect is restricted to mature osteoblasts and differentiated osteosarcoma because OSM effectively stimulates osteoblast markers and bone nodule formation in early, but not late, bone marrow mesenchymal stem cell (BMSC) cultures. In osteosarcoma cells or BMSC, OSM induces expression of the glial fibrillary acidic protein (GFAP) as well as morphological and ultrastructural changes, for example, elongated shape and bundles of microfilaments in cell processes. Rottlerin (PKCdelta inhibitor), and to a lesser degree UO126 (MEK/ERK inhibitor), prevents the loss of osteoblastic markers by OSM, whereas dominant negative STAT3 prevents GFAP induction. CONCLUSIONS: These results highlight the particular gene expression profile of OSM-treated osteosarcoma cells and BMSCs, suggesting either a osteocytic or a glial-like phenotype. Together with the implication of PKCdelta, ERK1/2, and STAT3, these results offer new lines of investigations for neural cell transplantation and osteosarcoma therapy. 相似文献
4.
Detection of the center of the hip joint in computer-assisted surgery: an evaluation study of the Surgetics algorithm. 总被引:4,自引:0,他引:4
Eric Stindel Daniel Gil Jean-Louis Briard Philippe Merloz Frédéric Dubrana Christian Lefevre 《Computer aided surgery》2005,10(3):133-139
OBJECTIVE: The aim of this paper is to assess the accuracy of an algorithm implemented by PRAXIM in the SURGETICS navigation station for detection of the hip center. This study will assess the robustness and accuracy of the algorithm in various clinical situations such as those involving non-sphericity of the femoral head, motion of the pelvis during hip center detection, and restricted range of motion. MATERIALS AND METHODS: The localization of the hip center, based on kinematics, relies on the recording of n successive positions of the femoral rigid body in the localizer reference system during a passive circumduction motion of the hip joint. Therefore, the shape of the clouds of points acquired may vary from one acquisition to the next. To allow a comprehensive study of the consequences of these variations for hip center detection, we developed a simulator to generate numerous clouds of points. Results given subsequently for each test are the values of the difference between the femoral mechanical axis computed with C(c), the computed hip center, and the same axis computed with C(o), the reference hip center. RESULTS: Test 1: Sensitivity to noise. The errors ranged from 3.33 E - 12 (SD 3.29E - 12) for a noise of 0 mm to 8.18E - 1 (SD - 7.05E - 1) for a noise of 15 mm. Test 2: Sensitivity to the shape of the acquisition motion. All trajectories gave an error < 1 degrees . Test 3: Sensitivity to restricted range of motion. No value > 1 degrees was found during this test. Test 4: Sensitivity to the distance between two points of the cloud. No value > 0.5 degrees was found during this test. Test 5: Sensitivity to the number of points included in the cloud. No value > 1 degrees was found during this test. CONCLUSIONS: The Surgetics algorithm is robust to noise, can compensate for pelvic motion, and can be used even in the case of restricted range of motion. 相似文献
5.
6.
7.
Chelyabinsk Medical Institute. (Presented by Academician of the Academy of Medical Sciences of the USSR A. D. Ado.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 113, No. 3, pp. 299–301, March, 1992. 相似文献
8.
E. A. Érenpreisa R. A. Zirne N. D. Zaleskaya T. G. Sjakste 《Bulletin of experimental biology and medicine》1988,106(5):1605-1608
Laboratory of Chemistry of the Cancer Cell, Latvian Research Institute of Experimental and Clinical Medicine, Ministry of Health of the Latvian SSR, Riga. (Presented by Academician of the Academy of Medical Sciences of the USSR I. B. Zbarskii.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 106, No. 11, pp. 591–593, November, 1988. 相似文献
9.
Jean-Marie Boeynaems Anne De Leener Barbara Dessars Hector Rodriguez Villa-Lobos Jean-Claude Aubry Frédéric Cotton Philippe Thiry 《Clinical chemistry and laboratory medicine》2004,42(1):67-71
Polyethylene terephthalate (PET) tubes have several advantages over glass tubes: they are unbreakable, lighter and more easily disposed of. Despite a steady increase in their use and an expansion of the range of available tubes, few studies validating their use have been published in the literature. This paper describes the various studies that have been performed to compare VENOJECT glass, VENOSAFE PET and VENOSAFE PET/heparin tubes for the assay of a panel of analytes in routine clinical chemistry, immunochemistry, hormone and tumor marker analysis and trace metal determination. These studies demonstrate that VENOSAFE PET tubes are a suitable alternative to glass tubes. 相似文献
10.